
"Big M" Mentors: Mentorship Can Be a Leadership Tool
Former Johnson & Johnson leader Seema Kumar reflects on her purpose as CEO of Cure, diversity, and why true mentorship involves more than offering tips.
Episodes
114
Latest episode
Nov 2026
Language
EN
Our podcasts bring alive important dialogues around leadership and transformation — all featuring proven leaders and leadership experts, talking about real-world challenges. Jump into one, and up your leadership game!

Former Johnson & Johnson leader Seema Kumar reflects on her purpose as CEO of Cure, diversity, and why true mentorship involves more than offering tips.

How have investments in the life sciences space changed over the last few years? Sara Michelmore from Milestone Advisors reflects and shares advice.

Getting More Resources. Show Them the Data. by The Vanguard Network

The majority of active pharmaceutical ingredients come from other countries. Whose responsibility is it to secure America’s future in healthcare innovation? Dr. Jeremy Levin is clear: everyone.

Resilience and focus. Neuroscientist Benjamin Bargetzi shares how these two qualities can help anyone manage trauma, leverage AI, and become better leaders.

What does a GC have that the average lawyer may not? Learn what longtime GC Heather White looks for, plus her take on how COVID and AI changed the game.

Is verbal identity as important to branding as graphics and other visuals? Find out as The Vanguard Network speaks to strategist and veteran copywriter Jim Larkin.

In this episode of Pharmaceutical Executive’s podcast series Leading Edge With Ken Banta, The Vanguard Network founder and CEO is joined by branding strategist Andy Milligan, founding partner of The Caffeine Partnership, where the duo examine why life sciences companies urgently need to rethink how they build, protect, and communicate their brands. From the erosion of trust in pharma to the disconnect between scientific innovation and patient experience, the discussion surfaces a core challenge: companies must evolve beyond product-centric messaging to patient-centric storytelling and emotional connection. The conversation also probes the unique tensions in healthcare — where cost, value, and trust collide — and outlines how leaders can retool brand engagement across stakeholders, including physicians, patients, payers, and investors. Highlights of the discussion with Michael Christel, MJH Life Sciences group managing editor, include: - Relevance + consistency = brand durability. Milligan underscores that strong brands evolve with customers while maintaining a clear, consistent identity — something many biopharma companies struggle to balance. - Trust is pharma’s defining — and fragile — currency. From pricing scrutiny to commercialization skepticism, the industry faces a persistent trust gap that branding must actively address. - The science-to-experience disconnect. While early-stage innovation earns high trust, that credibility often erodes at commercialization, creating a messaging challenge around value, cost, and access. - Storytelling as a strategic lever, especially in rare disease. Patient-centric narratives and simpler, more emotive messaging can bridge gaps across stakeholders and strengthen engagement across the care journey. Milligan advises CEOs and senior management teams on strategies for developing and exploiting brands and growing their business. He is a regular speaker at conferences internationally and has made frequent appearances in media, including on BBC, Sky, and CNN. Milligan has also published six best-selling books.

As general counsel, Tom Sabatino is very familiar with business upheaval. He tells the Vanguard Network why current upsets are different, and how leaders can keep cool.

During business disruptions, Anika Therapeutics CEO Cheryl Blanchard takes a no-nonsense approach with C-suite leaders. Find out how she does it without creating a toxic workplace culture.
Claim this listing to keep it up to date, reach guests who want to pitch you, and manage bookings with Guestify.
Claim this listing
Dr. Allen Lycka

Jessica Lorello and Maddison Donchez

Statera Asset Management

Tom Haugh

Brian Rose